Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Di Perri

Showing results (121-130 of 438) with videos related to

Pageof 44
Sort By:
Vaccines|December 28, 2021
Clinical Phenotype and Contagiousness of Early Breakthrough SARS-CoV-2 Infections after BNT162b2 COVID-19 mRNA Vaccine: A Parallel Cohort Study in Healthcare WorkersMattia Trunfio, Federica Verga, Valeria Ghisetti, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2015
A UPLC-MS-MS method for the simultaneous quantification of first-line antituberculars in plasma and in PBMCsLorena Baietto, Andrea Calcagno, Ilaria Motta, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 30, 2007
HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patientsAntonio D'Avolio, Marco Siccardi, Mauro Sciandra, et al.
The Journal of Antimicrobial Chemotherapy|January 7, 2006
Dose-dependent and genotype-independent sustained virological response of a 12 week pegylated interferon alpha-2b treatment for acute hepatitis CFrancesco G De Rosa, Olivia Bargiacchi, Sabrina Audagnotto, et al.
Journal of Chromatographic Science|July 24, 2008
A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patientsAntonio D'Avolio, Mauro Sciandra, Marco Siccardi, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 10, 2006
A simple and sensitive assay for determining plasma tipranavir concentration in the clinical setting by new HPLC methodAntonio D'Avolio, Mauro Sciandra, Marco Siccardi, et al.
BMC Infectious Diseases|December 3, 2013
Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxisFrancesco Giuseppe De Rosa, Ilaria Motta, Ernesta Audisio, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 25, 2013
Development and validation of a useful UPLC-MS/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patientsDanilo Agnesod, Amedeo De Nicolò, Marco Simiele, et al.
Antimicrobial Agents and Chemotherapy|May 7, 2014
Intracellular antiviral activity of low-dose ritonavir in boosted protease inhibitor regimensAmedeo De Nicolò, Marco Simiele, Andrea Calcagno, et al.
Infectious Diseases and Therapy|April 12, 2024
Ritonavir: 25 Years' Experience of Concomitant Medication Management. A Narrative ReviewRomina Quercia, Giovanni Di Perri, Carolina Pein, et al.
Pageof 44

Showing results (121-130 of 438) with videos related to

Sort By:
Pageof 44
Vaccines|December 28, 2021
Clinical Phenotype and Contagiousness of Early Breakthrough SARS-CoV-2 Infections after BNT162b2 COVID-19 mRNA Vaccine: A Parallel Cohort Study in Healthcare WorkersMattia Trunfio, Federica Verga, Valeria Ghisetti, et al.
The Journal of Antimicrobial Chemotherapy|June 13, 2015
A UPLC-MS-MS method for the simultaneous quantification of first-line antituberculars in plasma and in PBMCsLorena Baietto, Andrea Calcagno, Ilaria Motta, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|October 30, 2007
HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patientsAntonio D'Avolio, Marco Siccardi, Mauro Sciandra, et al.
The Journal of Antimicrobial Chemotherapy|January 7, 2006
Dose-dependent and genotype-independent sustained virological response of a 12 week pegylated interferon alpha-2b treatment for acute hepatitis CFrancesco G De Rosa, Olivia Bargiacchi, Sabrina Audagnotto, et al.
Journal of Chromatographic Science|July 24, 2008
A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patientsAntonio D'Avolio, Mauro Sciandra, Marco Siccardi, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|November 10, 2006
A simple and sensitive assay for determining plasma tipranavir concentration in the clinical setting by new HPLC methodAntonio D'Avolio, Mauro Sciandra, Marco Siccardi, et al.
BMC Infectious Diseases|December 3, 2013
Epidemiology of bloodstream infections in patients with acute myeloid leukemia undergoing levofloxacin prophylaxisFrancesco Giuseppe De Rosa, Ilaria Motta, Ernesta Audisio, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 25, 2013
Development and validation of a useful UPLC-MS/MS method for quantification of total and phosphorylated-ribavirin in peripheral blood mononuclear cells of HCV+ patientsDanilo Agnesod, Amedeo De Nicolò, Marco Simiele, et al.
Antimicrobial Agents and Chemotherapy|May 7, 2014
Intracellular antiviral activity of low-dose ritonavir in boosted protease inhibitor regimensAmedeo De Nicolò, Marco Simiele, Andrea Calcagno, et al.
Infectious Diseases and Therapy|April 12, 2024
Ritonavir: 25 Years' Experience of Concomitant Medication Management. A Narrative ReviewRomina Quercia, Giovanni Di Perri, Carolina Pein, et al.
Pageof 44